Status:
COMPLETED
Non-steroidal Anti-inflammatory Drugs Alone or With a Triptan and Reports of Transition From Episodic to Chronic Migraine
Lead Sponsor:
GlaxoSmithKline
Conditions:
Migraine Disorders
Eligibility:
All Genders
18+ years
Brief Summary
Chronic Migraine (CM), or 15 or more migraine headaches per month, is common in tertiary headache care and is associated with a number of deleterious outcomes, especially higher disability and poorer ...
Eligibility Criteria
Inclusion
- Respondents age 18 or older at the time of survey completion
- Respondents completed the questionnaires in 2004 and at least one other year (2005, 2006, 2007, 2008, 2009)
- Based on the respondents answers to the 2004 survey, their symptoms meet the criteria for EM which is characterized by headaches meeting International Classification of Headache Disorders - 2 (ICHD-2) criteria for migraine 1-14 days a month
Exclusion
- Responses to questions suggest that the respondent's diagnosis is not migraine or CM
Key Trial Info
Start Date :
September 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2011
Estimated Enrollment :
11249 Patients enrolled
Trial Details
Trial ID
NCT01435941
Start Date
September 1 2009
End Date
February 1 2011
Last Update
May 16 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.